The 10th China Listed Companies Summit Week in 2021 sponsored by National Business Daily was grandly held online through the omnimedia platform of NBD. At the conference, the highly anticipated 11th Reputation List of China Listed Companies was announced simultaneously. Tibet Pharmaceutical stood out among many outstanding listed companies and was awarded the Most Growable Listed Company in Biomedicine.
The Reputation List was tested in four links: public nomination, big data screening, model screening and institution + public voting. It considered the A-share market from multiple dimensions to find outstanding listed companies in China. This award is a high recognition of Tibet Pharmaceutical by the media and investors in the field of biomedicine, which fully reflects the capital markets affirmation of the future development potential of Tibet Pharmaceutical.

Tibet Pharmaceutical has always adhered to the concept of "Science Achieves Health, and Health Makes Future" and developed its business with science and technology. On the premise of standardized operation and risk prevention and control, the Company will make continuous efforts to do a good job in management and operation and improve corporate performance. In the future, Tibet Pharmaceutical will continue to make innovation and progress as always, strive to continuously return the support and trust from investors and media with good performance, and continue to consolidate and enhance the industry status and capital market image.